Leadership in attendance in Barcelona ready to talk to potential partners and collaborators
GRAND RAPIDS, Mich., Oct. 18, 2023 /PRNewswire/ -- Corium Innovations, Inc. , a leading, full-service contract development and manufacturing organization specializing in novel drug delivery technologies, announced today that it will be featuring its industry leading transdermal, microarray and oral thin film technologies at booth 80N27 during the upcoming CPHI Barcelona 2023, to be held October 24-26 in Barcelona, Spain.
With 25 years of making and leveraging groundbreaking transdermal delivery systems since it was founded, Corium Innovations maintains fully integrated research & development capabilities along with annual manufacturing capacity of more than 200 million transdermal patches/films at its 200,000 square foot GMP facility in Grand Rapids, Michigan. Corium Innovations brings the best of its proprietary transdermal and transmucosal delivery platforms to different patient and consumer groups in customary or challenging usage situations.
"Our passion for continually cracking the code in drug delivery is proven and enables us to deliver more than medicine. It enables us to deliver healthier outcomes," said Dr. Mark Sirgo, Chief Executive Officer at Corium Innovations. "Our teams of scientists and engineers never stop finding ways to create solutions for partners by adapting our tunable technologies for a vast range of therapies, including biologics. We keep pushing forward to develop high-value brands and complex generic products. Both for the partners we work for today – and for those in the future."
Read More: PRNewswireNews - Jornalwebdigital
0 Comments